In recent years, emerging data have demonstrated the role of activation of the NLRP3 inflammasome in the pathogenesis of NASH, where NLRP3 plays an important role in the detection of inflammatory signals and conversion of these into an inflammatory response in the gut–liver axis. Here, NLRP3 is linked to metabolic dysfunction-associated steatohepatitis.